Amphenol Corporation (APH) vs AstraZeneca PLC (AZN)
AZN leads on 9 of 16 compared metrics.
A side-by-side comparison of Amphenol Corporation and AstraZeneca PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — APH vs AZN
growth of $100 · last 30yAPH +40490.1%AZN +732.9%APH compounded faster
Log scale — wide-divergence pair
APH AZN
APH vs AZN: by the numbers
- •AZN is the larger company ($277.22B vs $189.21B market cap).
- •AZN trades at the lower earnings multiple (26.92 vs 44.20 P/E).
- •APH grew revenue faster over the past five years (23.24% vs 16.99% CAGR).
- •AZN pays the higher dividend yield (1.79% vs 0.54%).
Which is better, APH or AZN?
Metric tally: APH 7 · AZN 9It depends on what you're optimizing for:
ValueAZN(lower P/E)
GrowthAPH(faster 5Y revenue CAGR)
IncomeAZN(higher dividend yield)
QualityAPH(higher ROIC)
Metrics side by side
Valuation
| Metric | APH | AZN |
|---|---|---|
| P/E ratio | 44.20 | 26.92● |
| Forward P/E | 32.36 | 15.33● |
| P/S ratio | 7.66 | 4.62● |
| P/B ratio | 14.19 | 5.90● |
| PEG ratio | 0.52 | 0.14● |
| EV / EBITDA | 26.77 | 14.92● |
| FCF yield | 2.33% | 2.89%● |
Profitability
| Metric | APH | AZN |
|---|---|---|
| Gross margin | 37.35% | 81.68%● |
| Operating margin | 26.00%● | 23.69% |
| Net margin | 17.28% | 17.19% |
| ROE | 32.02%● | 21.95% |
| ROIC | 15.12%● | 13.03% |
Dividends
| Metric | APH | AZN |
|---|---|---|
| Dividend yield | 0.54% | 1.79%● |
| Payout ratio | 23.65% | 48.48% |
Growth (annualized)
| Metric | APH | AZN |
|---|---|---|
| Revenue CAGR (5Y) | 23.24%● | 16.99% |
| EPS CAGR (5Y) | 28.30%● | 22.02% |
| FCF CAGR (5Y) | 30.28%● | 15.68% |
| Total return CAGR (5Y) | 36.28%● | 11.03% |
Frequently asked
- Which is better, APH or AZN?
- It depends on your goal. value: AZN (lower P/E); growth: APH (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: APH (higher ROIC). Across all compared metrics, AZN leads 9 to 7.
- Is APH or AZN cheaper?
- On trailing earnings, AZN is cheaper: APH trades at a 44.20 P/E and AZN at 26.92.
- Which has grown faster, APH or AZN?
- Over the past five years, APH grew revenue faster — APH at a 23.24% CAGR versus AZN at 16.99%.
- Does APH or AZN pay a bigger dividend?
- APH yields 0.54% and AZN yields 1.79% based on trailing dividends and the latest price.
- Which has been the better investment, APH or AZN?
- Over the past 10-year, APH delivered the higher annualized total return — APH at 27.47% versus AZN at 15.77%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amphenol P/E ratioAstraZeneca P/E ratioAmphenol dividend yieldAstraZeneca dividend yieldAmphenol ROEAstraZeneca ROEAmphenol operating marginAstraZeneca operating marginAmphenol revenue growthAstraZeneca revenue growthAmphenol free cash flowAstraZeneca free cash flow
Amphenol & AstraZeneca appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.